 Ramelteon was developed by Takeda Pharmaceutical Company and approved in the United States in 2005.Agomelatine was developed by the pharmaceutical company Servier and approved in Europe 2009.Tasimelteon was developed by Vanda Pharmaceuticals and completed the phase III trial in 2010.